(Q73280015)
Statements
Initial report on intravesical administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladder (English)
R E Greenberg
R R Bahnson
D Wood
S J Childs
C Bellingham
M Edson
M H Bamberger
G D Steinberg
M Israel
T Sweatman
B Giantonio